Company / Interest Expense per Share
NeoGenomics Laboratories, Inc. Interest Expense per Share History
FY2017-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2023
5-year range
$0.06 / $0.07
FY2019-FY2023
Trend
-9.8%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s interest expense per share of $0.06 is lower than 88% of companies in the Health Care sector (FY2023). Improved from $0.07 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2023 with a 5-year CAGR of -4.2%.
Improved from $0.07 to $0.06 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.06 Sector average $1.48
▼
-96.3% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 9.8% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2017.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.06 | -9.8% |
| FY2022 | $0.06 | -10.9% |
| FY2021 | $0.07 | +9.1% |
| FY2020 | $0.06 | +75.2% |
| FY2019 | $0.04 | -47.3% |
| FY2018 | $0.07 | -3.5% |
| FY2017 | $0.07 | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026